Quantcast
Last updated on April 21, 2014 at 12:39 EDT

Latest Becker's muscular dystrophy Stories

2012-09-27 06:29:05

University of Alberta Professor to be Given Grant to Continue Potentially Groundbreaking Work in Duchenne Muscular Dystrophy HACKENSACK, N.J., Sept. 27, 2012 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD) announced today that it will award the University of Alberta's Toshifumi Yokota, Ph.D. a $50,000 grant to continue his work in exon skipping as a potential therapy for Duchenne muscular dystrophy. Dr. Yokota is the Assistant Professor and Research Chair in...

2012-09-19 02:25:06

WACO, Texas, Sept. 19, 2012 /PRNewswire-USNewswire/ -- For the fifth year in a row, college football coaches nationwide will join together in support of the Coach To Cure MD program, which will be held during games of Saturday, September 29, 2012. The rapidly growing annual effort has raised more than a million dollars to battle Duchenne muscular dystrophy. (Logo: http://photos.prnewswire.com/prnh/20100119/DC39975LOGO ) On September 29th, American Football Coaches Association (AFCA) members...

2012-09-17 06:28:41

Dongsheng Duan, Ph.D. to be Given Grant to Continue Work With SERCA2a in Duchenne Muscular Dystrophy HACKENSACK, N.J., Sept. 17, 2012 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD) announced today that it will award the University of Missouri's Dongsheng Duan, Ph.D. a $280,000 grant to continue his work to treat cardiomyopathy in Duchenne muscular dystrophy through a gene therapy approach. (Logo: http://photos.prnewswire.com/prnh/20100119/DC39975LOGO) Dr. Duan...

Underlying Causes Of Impaired Brain Function In Muscular Dystrophy Revealed
2012-08-08 12:54:58

The molecular missteps that disrupt brain function in the most common form of adult-onset muscular dystrophy have been revealed in a new study published by Cell Press. Myotonic dystrophy is marked by progressive muscle wasting and weakness, as well as excessive daytime sleepiness, memory problems, and mental retardation. A new mouse model reported in the August 9 issue of the journal Neuron reproduces key cognitive and behavioral symptoms of this disease and could be used to develop drug...

2012-08-02 07:03:06

(Ivanhoe Newswire) - Duchenne muscular dystrophy affects 1 in every 3,600 male infants each year. Due to the way the disease is inherited, girls are not affected. Muscular dystrophy consists of a group of inherited disorders causing muscle weakness and loss of muscle tissue, which progressively becomes worse. Researchers seem to have discovered a promising new way to reverse the symptoms of the disease in mice. Scientists have reversed symptoms of myotonic muscular dystrophy in mice by...

2012-07-23 02:25:28

SOUTH PLAINFIELD, N.J., July 23, 2012 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the completion of a $30 million financing. The round included a number of long-term investors such as Credit Suisse First Boston Equity Partners, HBM BioVentures, Vulcan Ventures, Celgene, Delphi Ventures, The Column Group, Novo A/S, and other existing investors. (Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO) "This funding will support our continued late-stage clinical...

2012-06-27 02:27:17

SOUTH PLAINFIELD, N.J., June 27, 2012 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of an open-label study in the European Union, Israel, Australia and Canada for patients with nonsense mutation Duchenne/Becker muscular dystrophy (nmDBMD) who received ataluren in a prior, PTC-sponsored clinical study. The primary objective of this study is to gain further information on the long-term safety and tolerability of ataluren, an investigational new drug. PTC launched a...

2012-06-25 02:26:07

Meeting to Take Place at Annual Connect Conference in Ft. Lauderdale HACKENSACK, N.J., June 25, 2012 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD) will host the first Transforming Duchenne Care Meeting, June 27-28, 2012, immediately preceding the Annual Connect Conference in Fort Lauderdale, Florida. The goal of the Transforming Duchenne Care Meeting is to bring together leadership from top medical institutions, neuromuscular experts, and patient representatives to...

2012-06-22 11:52:36

'A Molecular Bandage for Diseased Muscle' appears today in prestigious Science publication Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published this week in Science Translational Medicine. "This is a focus article in which we summarize the impact of MG53 protein therapy as a treatment option and discuss the...

2012-06-20 10:23:04

HACKENSACK, N.J., June 20, 2012 /PRNewswire-USNewswire/ -- AVI BioPharma is teaming up with Parent Project Muscular Dystrophy (PPMD)'s endurance program, Run For Our Sons, to participate in the Rock 'n' Roll Seattle Marathon & Half Marathon on June 23, 2012. The goal is to raise money and awareness to help end Duchenne muscular dystrophy (Duchenne), the most common form of muscular dystrophy. (Logo: http://photos.prnewswire.com/prnh/20100119/DC39975LOGO) AVI and PPMD have a long...